October 23, 2024
Umbrella trial design will link multiple NCI-supported studies to allow patients with newly diagnosed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) to register to clinical trials throughout the course of their cancer treatment.
Four leading cancer research organizations in the United States and Canada announce the opening of patient enro
Congratulations to the Memorial Sloan Kettering Cancer Center (MSK) for the 2024 Alliance Fall Hybrid Group Meeting Book cover design. Darren Feldman, MD, is the Principal Investigator of the NCTN LAPS Grant. For more than three decades, U.S. News & World Report has consistently recognized MSK as one of t
October 15, 2024
Alliance A032102: PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)
Overview: Rana McKay, MD, of University of California San Diego Health, leads Alliance A032102 (PREDICT) - a phase II trial to evaluate whether genetic testing in prostate cancer is helpful in deciding which study treatment patients are assigned. Patient cancer tissue samples are obtained from a previous surgery or biopsy proc
